Related Experiment Video
Updated: Jul 6, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Barriers to obesity treatment
Marina Mauro1, Valerie Taylor, Sean Wharton
1Department of Medicine, McMaster University, Hamilton, ON, Canada.
European Journal of Internal Medicine
|April 9, 2008
Summary
Obesity management requires lifelong treatment due to its chronic nature. Addressing patient barriers, like comorbidities and socioeconomic factors, is crucial for successful long-term weight management.
Area of Science:
- Medical Science
- Public Health
Background:
- Obesity is a prevalent, chronic, and progressive health condition requiring lifelong management.
- Current obesity treatments often show poor long-term efficacy and effectiveness.
- Numerous barriers hinder successful long-term obesity management strategies.
Purpose of the Study:
- To identify and discuss barriers impacting long-term obesity management.
- To emphasize the need for healthcare professionals to address these barriers.
- To highlight the potential for improved patient outcomes and resource savings.
Main Methods:
- Literature review and synthesis of factors affecting obesity treatment adherence.
- Analysis of patient-related, healthcare system-related, and societal barriers.
- Discussion of the impact of comorbidities and their treatments on weight management.
Main Results:
- Barriers include lack of recognition of obesity as a chronic disease, socioeconomic status, time constraints, and comorbidities (mental health, sleep, pain, cardiovascular, etc.).
- Medications for comorbidities can impede weight loss efforts.
- Inadequate health professional training, negative attitudes, and limited treatment access are significant barriers.
Conclusions:
- Healthcare professionals must actively identify, acknowledge, and address barriers to improve patient success, compliance, and adherence.
- Failure to address barriers can exacerbate feelings of failure and low self-efficacy in patients.
- Overcoming these obstacles is essential for long-term success in obesity management and resource optimization.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Barriers to Effective Communication II
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...